We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Guidance Addresses Neurothrombectomy Device Studies
In a new guidance, the U.S. Food and Drug Administration (FDA) describes its recommendations for preclinical and clinical studies to support 510(k)s for neurothrombectomy devices indicated for ischemic stroke.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor